Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum CalciMedica Inc CALC

CalciMedica, Inc. is a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for acute and chronic inflammatory and immunologic illnesses. The Company's technology targets the inhibition of CRAC channels to modulate the immune response and protect against tissue cell injury. Its lead product candidate is Auxora... see more

NDAQ:CALC - Post Discussion

CalciMedica Inc > Perspectives ....just a thought Gray vs Star Peak
View:
Post by Timberdoodle on May 13, 2021 12:55pm

Perspectives ....just a thought Gray vs Star Peak

As many others on this board took a serious beating following lastt halt by CSE, since I'm also interested by STE.V  I would suggest you have a look on both respective setup ...size, claims, infrastructure (old mine nearby).  One is very coveted and becoming a rising star (STE) and the other was sadly manipulated & dumped big time (GRAY ) I know and learned the hard way still there are striking similarities should Gray show some good grades in a not too distant future. JMHO
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities